The company has received approval from an independent commission to begin the first human trial of a brain implant for patients with paralysis.
The study will test the safety and effectiveness of the wireless implantable brain-computer interface Neuralink to enable people with paralysis to control external electronic devices with their minds.
Neuralink clarified that patients with paralysis due to cervical spinal cord injury or amyotrophic lateral sclerosis will participate in the trial.
Two years earlier, Musk’s company implanted its technology into a pig’s head, and a little more than 19 months later, into a monkey.
On December 1, 2022, Elon Musk announced the testing of the chip on humans.